Medical and Pharmaceutical Industries

Who we are
We are scientists, engineers, and business professionals; driving breakthroughs in fields as diverse as aerospace, automotive, energy, defense, healthcare, and telecommunications.

We research, develop and commercialize innovative technologies:

Strain & temperature sensing
Test and measurement
Shape sensing

We conduct applied research for customers in our primary areas of focus:

Sensing and instrumentation
Advanced materials
Health sciences

Why it matters

Nanocopoeia is a drug delivery company developing a nanotechnology-enabled portfolio of therapeutic products. The business of Nanocopoeia is the therapeutic use of those nanoparticles in medical applications. Our patented ElectroNanospray™ (ENS) process is currently being used to produce complex coatings for medical devices and to nanoformulate drugs.

Focused on novel, nanotechnology-based therapeutics.

Cerulean Pharma Inc. is a clinical-stage biopharmaceutical company specializing in the design and development of nanopharmaceuticals. Cerulean’s nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance efficacy and tolerability of therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules.

Cerulean is pursuing three key strategies:

- Located in Madison, Wisconsin, since 1910
- Nation's only federally funded wood utilization research laboratory
- Currently employs 60 Research Scientists
- Primarily or partly responsible for many of today's wood-based technologies, including wood preservatives, glulam beams, oriented strandboard, and fiber-based packaging
- Research partnerships located in virtually every state in the Nation
- Reduced timber demand for railroad ties by 75% through preservatives research
- Increased average lumber yield per log from 25% to 60%

PChem’s technology includes novel materials (inks), print processing trade secrets, and know how that in total provide PChem with a competitive advantage in the exciting and rapidly growing printed electronics market space.

The Microproducts Breakthrough Institute is a unique collaboration between Oregon State University and the Pacific Northwest National Laboratory focused on the development and commercialization of microchannel-based technologies for energy, medical, environmental and national security applications. Formed in 2003, the MBI model is to include academic, federal laboratory and industrial researchers in the same facility and to support the researchers with unique fabrication, modeling and testing capabilities tailored to the development of microchannel devices.

Our Mission